Prognosis for women with epithelial ovarian cancer remains poor. One new molecular target in epithelial ovarian cancer is folate receptor alpha (FRα). This commentary discusses the characteristics that contribute to its attractiveness as a candidate for therapeutic intervention.
No takes yet. Share an insight, caveat, or question.
Birrer et al. (2019) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: